Agenus | AGEN - Market Capitalization


Agenus reported $2.72B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Agenus USD 128M 21M Mar/2026
Amgen USD 195.44B 5.55B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Celldex Therapeutics USD 2.92B 809M Jun/2026
CSL USD 55.89B 20.42B Dec/2025
Eli Lilly USD 1.13T 260.54B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Incyte USD 22.65B 3.92B Jun/2026
J&J USD 599.1B 54.52B Oct/2026
Jiangsu Hengrui CNY 344.89B 22.02B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
MacroGenics USD 184M 82M Mar/2026
Merck EUR 18.98B 27.8B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Northwest Biotherapeutics USD 332M 24M Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026